Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced it has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate...
Amytrx and Amarex Clinical Research, LLC, an NSF company, announced they are initiating the Phase II clinical trial on atopic dermatitis (AD) using Amytrx's...